
<table>
    <thead>
        <tr>
            <th rowspan="3">Assessment</th>
            <th colspan="3">Pre-Treatment Phase</th>
            <th colspan="6">Treatment Phase</th>
            <th colspan="2">Post-Treatment Phase</th>
        </tr>
        <tr>
            <th rowspan="2">Screening</th>
            <th colspan="4">Cycle 1</th>
            <th colspan="2">Cycle 2, 4, 6 etc.</th>
            <th colspan="2">Cycle 3, 5, 7 etc.</th>
            <th rowspan="2">EOT</th>
            <th rowspan="2">1M FUP</th>
        </tr>
        <tr>
            <th>D1</th>
            <th>D8 (±2)</th>
            <th>D15 (±2)</th>
            <th>D22 (±2)</th>
            <th>D1</th>
            <th>D15 (±2)</th>
            <th>D1</th>
            <th>D15 (±2)</th>
        </tr>
        <tr>
            <th>Visit Window (± days)</th>
            <th>D-14 to D-1</th>
            <th colspan="4"></th>
            <th colspan="2"></th>
            <th colspan="2"></th>
            <th>≤ 10 d from the decision of trial treatment withdrawal</th>
            <th>1 month after last dose of trial treatment (28+7d)</th>
        </tr>
    </thead>
    <tbody>
        <tr>
            <td class="assessment-category">Informed Consent</td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
        </tr>
        <tr>
            <td class="assessment-category">Baseline Characteristics/Eligibility<sup>2</sup></td>
            <td>X</td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
        </tr>
        <tr>
            <td class="section-header" colspan="12">Safety Assessments</td>
        </tr>
        <tr>
            <td>Medication Survey</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
        </tr>
        <tr>
            <td>(S)AE Survey and Reporting</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
        </tr>
        <tr>
            <td>DLT Evaluation (dose-escalation only)<sup>3</sup></td>
            <td></td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>C2/D1</td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
        </tr>
        <tr>
            <td>Vital Signs and Body Weight</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td></td>
            <td></td>
        </tr>
        <tr>
            <td>ECOG PS</td>
            <td>X</td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
        </tr>
        <tr>
            <td>Physical Examination</td>
            <td>X</td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
        </tr>
        <tr>
            <td>Dermatological Examination</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td></td>
            <td></td>
        </tr>
        <tr>
            <td>ECG<sup>4</sup></td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td>X</td>
            <td></td>
        </tr>
        <tr>
            <td>Safety blood samples<sup>5</sup></td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
        </tr>
        <tr>
            <td>Urinalysis<sup>5</sup></td>
            <td>X</td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
        </tr>
        <tr>
            <td>Pregnancy Test</td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td>X</td>
            <td></td>
        </tr>
        <tr>
            <td class="section-header" colspan="12">Disease Assessments</td>
        </tr>
        <tr>
            <td>(Archival) Tumor Biopsy Collection<sup>6,7</sup></td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
        </tr>
        <tr>
            <td>Tumor Marker Evaluation<sup>8</sup></td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td>End of C</td>
            <td></td>
            <td></td>
            <td></td>
            <td>X</td>
            <td>X</td>
        </tr>
        <tr>
            <td>Disease Status Evaluation by CT/ MRI<sup>9,10</sup></td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td>End of C</td>
            <td></td>
            <td></td>
            <td></td>
            <td>X</td>
            <td>X</td>
        </tr>
        <tr>
            <td class="section-header" colspan="12">*Additional Assessments</td>
        </tr>
        <tr>
            <td>*PK Samples (dose-escalation only)<sup>11</sup></td>
            <td></td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
        </tr>
        <tr>
            <td>*ADA Sample</td>
            <td>X</td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
            <td>X</td>
            <td></td>
        </tr>
        <tr>
            <td>*Biomarker Blood and Urine Sample<sup>12</sup></td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
            <td></td>
            <td>End of C2</td>
            <td></td>
            <td></td>
            <td></td>
            <td>X</td>
            <td></td>
        </tr>
        <tr>
            <td class="section-header" colspan="12">Trial Treatment</td>
        </tr>
        <tr>
            <td>Skin Toxicity Prophylaxis and TX<sup>13</sup></td>
            <td></td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
            <td>X</td>
        </tr>
        <tr>
            <td>Infusion Reaction Prophylaxis<sup>14</sup></td>
            <td></td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
        </tr>
        <tr>
            <td>Sym004 Infusion</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
        </tr>
        <tr>
            <td>Gastrointestinal Toxicity Prophylaxis<sup>15</sup></td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
        </tr>
        <tr>
            <td>FOLFIRI Infusion</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
        </tr>
        <tr>
            <td>Post-Infusion Monitoring</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td>X</td>
            <td></td>
            <td></td>
            <td></td>
        </tr>
    </tbody>
</table>